KEVIN JIMENEZ: Open Payments
NPI 1023607553 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 11 payments from 7 companies in 2025. Trend: 2023 $286 · 2024 $454 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| PFIZER INC. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $37 |
| SCPHARMACEUTICALS INC. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
Products named: ELIQUIS, VERQUVO, FUROSCIX, CAMZYOS, LEQVIO, LifeVest.
Industry payments across CT — which companies pay providers there.
